arrow_back Back to App

September Designated as Polycystic Kidney Disease Awareness Month: Support and Research

The House of Representatives supports designating September 2024 as National Polycystic Kidney Disease (PKD) Awareness Month. The goal is to increase public understanding of this genetic kidney disorder, which affects approximately half a million Americans, and to emphasize the need for further research into treatments and a cure. This initiative aims to help citizens better understand PKD's impact on daily life and encourage support for educational efforts.
Key points
Raising public awareness about polycystic kidney disease (PKD), one of the most prevalent genetic kidney disorders.
Highlighting the need for additional research to find effective treatments and a cure for PKD.
Encouraging support for educational and informational activities related to PKD to assist patients and their families.
Recognizing the impact of PKD on the health and finances of affected individuals, regardless of age, race, or gender.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1505
Sponsor: Rep. Cleaver, Emanuel [D-MO-5]
Process start date: 2024-09-25
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 2024 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1505.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-09-25.

What are the main provisions?

Key points include:

  • Raising public awareness about polycystic kidney disease (PKD), one of the most prevalent genetic kidney disorders.
  • Highlighting the need for additional research to find effective treatments and a cure for PKD.
  • Encouraging support for educational and informational activities related to PKD to assist patients and their families.
  • Recognizing the impact of PKD on the health and finances of affected individuals, regardless of age, race, or gender.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Cleaver, Emanuel [D-MO-5].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health